EU doubles contribution to COVAX to €1 billion to ensure safe and effective vaccines for low and middle-income countries

22-02-2021
EU doubles contribution to COVAX to €1 billion to ensure safe and effective vaccines for low and middle-income countries
EU doubles contribution to COVAX to €1 billion to ensure safe and effective…
Copyright: European Commission

The European Union announced on 19 February an additional €500 million for the COVAX Facility, doubling its contribution to date for the global initiative that is leading efforts to secure fair and equitable access to safe and effective COVID-19 vaccines in low and middle-income countries. This new pledge brings the EU closer to achieving COVAX's target to deliver 1.3 billion doses for 92 low and middle income countries by the end of 2021. Team Europe is one of the lead contributors to COVAX with over €2.2 billion, including another €900 million pledged by Germany.

The contribution announced last week is composed of a new €300 million EU grant and €200 million in guarantees by the European Fund for Sustainable Development plus (EFSD+) that will back a loan by the European Investment Bank.

COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator, a global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.

 

Read more

Press release

Video

EU Global Response to coronavirus